Tel.: +33-1-42-49-95-65, Fax: +33-1-42-38-54-76
1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
Cancer Cell Biology
You have full text access to this OnlineOpen article
β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells
Article first published online: 12 MAY 2010
DOI: 10.1002/ijc.25455
Copyright © 2010 UICC
Additional Information
How to Cite
Moreau, M., Mourah, S. and Dosquet, C. (2011), β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells. Int. J. Cancer, 128: 1280–1292. doi: 10.1002/ijc.25455
Publication History
- Issue published online: 28 JAN 2011
- Article first published online: 12 MAY 2010
- Manuscript Accepted: 28 APR 2010
- Manuscript Received: 23 DEC 2009
Funded by
- INSERM
- Ministère de la Recherche, France, Conseil Regional d'Ile-de-France
References
- 1, . Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362–74.
- 2. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997; 91: 439–42.
- 3, , , , , , . Plasminogen activation and cancer. Thromb Haemost 2005; 93: 676–81.
- 4. The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 2004; 10: 39–49.
- 5, , , , , , . Tumor stroma is the predominant uPA-, uPAR-. PAI-1-expressing tissue in human breast cancer: prognostic impact. Histol Histopathol 2009; 24: 869–77.
- 6, , , , . Inhibition of angiogenesis and invasion by 3,3′-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 2007; 67: 3310–19.
- 7, . The plasminogen activator system and cancer. Pathophysiol Haemost Thromb 2008; 36: 184–94.
- 8, , , , , , , , , , , , et al. Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors. Cancer Res 2004; 64: 1209–14.
- 9. Wnt signaling in disease and in development. Cell Res 2005; 15: 28–32.
- 10. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469–80.
- 11, . The opposing roles of Wnt-5a in cancer. Br J Cancer 2009; 101: 209–14.
- 12, , , , . GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Oncogene 2000; 19: 537–45.
- 13, , , , , . Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009; 9: 489–99.
- 14, , , , . Genetic mechanisms in Apc-mediated mammary tumorigenesis. PLoS Genet 2009; 5: e1000367.
- 15, , , , , , . The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522–7.
- 16, , , , , , , , . Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509–12.
- 17, , , , . beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155: 1033–8.
- 18, , . Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 2001; 61: 6050–4.
- 19, , , . Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells. Oncogene 2010; 29: 128–38.
- 20, , , , , , . uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Exp Cell Res 2001; 264: 326–36.
- 21, , . A labile repressor acts through the NFkB-like binding sites of the human urokinase gene. Nucleic Acids Res 1991; 19: 3389–93.
- 22, , , , , . Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur J Biochem 2000; 267: 3248–54.Direct Link:
- 23, , , , , , . Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. J Biol Chem 2004; 279: 18127–36.
- 24, , , , , , . Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells. FEBS Lett 2008; 582: 616–22.
- 25, , , , , , , , . beta-Catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2002; 2: 323–34.
- 26, , . Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996; 6: 1664–8.
- 27, , , , , , , , . Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci 2002; 115: 2771–80.
- 28, , , , , , , , . Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 2007; 67: 6844–53.
- 29, , , , . Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene 2002; 21: 5861–7.
- 30, , , , . Gene silencing of beta-catenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in mice. Int J Cancer 2008; 123: 2315–20.Direct Link:
- 31, , , , , , , , , , . Ablation of p120-catenin enhances invasion and metastasis of human lung cancer cells. Cancer Sci 2009; 100: 441–8.Direct Link:
- 32, , , , , . Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway. Mol Carcinog 2004; 39: 139–46.Direct Link:
- 33, , , , , , . Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res 2009; 69: 3764–71.